Candida: Difference between revisions

From IDWiki
Candida
m (: tidied table)
(: linkified)
Line 59: Line 59:
* First-line:
* First-line:
** '''Remove lines!'''
** '''Remove lines!'''
** GGT positive: fluconazole for 2 weeks after first negative blood culture
** GGT positive: [[Is treated by::fluconazole]] for 2 weeks after first negative blood culture
** GGT negative: move to second-line therapies
** GGT negative: move to second-line therapies
* Second-line: micafungin, then amphotericin B (last choice)
* Second-line: [[Is treated by::micafungin]], then [[Is treated by::amphotericin B]] (last choice)
* Endophthalmitis: extend course to 4 weeks
* Endophthalmitis: extend course to 4 weeks
* Failure of therapy: double-check for endophthalmitis
* Failure of therapy: double-check for endophthalmitis

Revision as of 17:32, 19 November 2019

  • Most common medically-important genus of yeast

Microbiology

  • Budding yeast

Organisms

Clinical Presentation

  • Most common: mouth, vagina, skin
  • In immunocompromised, ICU, IVDU, or TPN patients: Esophagus, blood, CNS, endophthalmitis
  • Less common: joint
  • IVDU: endocarditis

Investigations

  • Urine culture if concern for cystitis
  • Blood culture
    • Never ignore candidemia!
    • Requires an ophthalmology consult to rule out endophthalmitis (1-3% of cases)
    • Echocardiogram if IVDU or prosthetic valve
  • Germ tube test (GTT)
    • If positive, indicates C. albicans or C. dubliniensis
    • Identifies fluconazole-sensitive Candidae

Species and Resistance

Species Resistance pattern
C. albicans Generally fluconazole-susceptible
C. dubliniensis Generally fluconazole-susceptible
C. parapsilosis Generally fluconazole-susceptible
C. glabrata Often fluconazole resistant, or dose-dependent
C. tropicalis Generally fluconazole-susceptible
C. krusei Inherent fluconazole resistance
C. lusitaniae Often amphotericin resistant but fluconazole-susceptible

Treatment

  • First-line:
    • Remove lines!
    • GGT positive: fluconazole for 2 weeks after first negative blood culture
    • GGT negative: move to second-line therapies
  • Second-line: micafungin, then amphotericin B (last choice)
  • Endophthalmitis: extend course to 4 weeks
  • Failure of therapy: double-check for endophthalmitis